EMILY NEWTON: Open Payments
NPI 1215713508 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 81 payments from 13 companies in 2025. Trend: 2023 $112 · 2024 $1,208 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $271 |
| ABBVIE INC. | 26 | $251 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Corium, LLC | 8 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Alkermes, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $57 |
Products named: FANAPT, VRAYLAR, REXULTI, Azstarys, CAPLYTA, LYBALVI, COBENFY, Auvelity.
Industry payments across KY — which companies pay providers there.
